First Time Loading...

NLS Pharmaceutics AG
NASDAQ:NLSP

Watchlist Manager
NLS Pharmaceutics AG Logo
NLS Pharmaceutics AG
NASDAQ:NLSP
Watchlist
Price: 0.1326 USD -6.29%
Updated: May 10, 2024
Section:
 

Wall Street
Price Targets

NLSP Price Targets Summary
NLS Pharmaceutics AG

There are no price targets for NLSP.
NLSP Lowest Forecast
Wall Street Target
Not Available
NLSP Average Forecast
Wall Street Target
Not Available
NLSP Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NLS Pharmaceutics AG Competitors:
Price Targets
VETO
Vetoquinol SA
10% Upside
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
50% Upside
G
002275
Guilin Sanjin Pharmaceutical Co Ltd
8% Upside
H
106190
High Tech Pharm Co Ltd
116% Upside
VETO
Vetoquinol SA
10% Upside
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
50% Upside
G
002275
Guilin Sanjin Pharmaceutical Co Ltd
8% Upside
H
106190
High Tech Pharm Co Ltd
116% Upside
GRANULES
Granules India Ltd
17% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
11% Downside
SUPN
Supernus Pharmaceuticals Inc
43% Upside
SWDCF
Swedencare AB (publ)
41% Upside

Revenue
Forecast

Revenue Estimate
NLS Pharmaceutics AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
NLS Pharmaceutics AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
NLS Pharmaceutics AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
What are analyst estimates?

See Also

Summary
NLSP intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLSP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLSP stock valuation using valuation multiples.
Wall Street Estimates
NLSP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLSP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NLSP's stock price target?
Not Available

NLSP doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 136,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.